tiprankstipranks
Zura Bio Clarifies Legal Status of Information Release
Company Announcements

Zura Bio Clarifies Legal Status of Information Release

Don't Miss our Black Friday Offers:

Zura Bio (ZURA) has shared an announcement.

Zura Bio Limited (ZURA) has released a press statement, emphasizing that the act of sharing this information via a Current Report does not imply its significance under Regulation FD. Furthermore, the company clarifies that the content of this report and its attachments are not considered “filed” for legal purposes, unless explicitly stated otherwise by the company. This distinction ensures that the information is not automatically subject to certain legal liabilities.

Find detailed analytics on ZURA stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskZura Bio Announces Phase 2 Tibulizumab Study
TheFlyZura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
TheFlyZura Bio price target raised to $12 from $11 at Chardan
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App